Elders Preferences in Care Decisions (EPIC-D)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Duke University
Information provided by (Responsible Party):
Carmen Lewis, MD, MPH, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01575990
First received: March 29, 2012
Last updated: April 16, 2012
Last verified: April 2012

March 29, 2012
April 16, 2012
March 2012
March 2014   (final data collection date for primary outcome measure)
Appropriate colorectal cancer screening [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
The proportion of participants classified as having appropriate colorectal cancer screening in the intervention group compared to the control group. Appropriate screening is a combined outcome measure using patient report of completion or non-completion of CRC screening tests and patient report of discussions about CRC screening with their provider at the index visit. The outcome will be measured six months after the index visit. The index visit is the patient/provider visit that occurred after the decision support intervention or control condition was administered.
Appropriate colorectal cancer screening [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
The proportion of participants classified as having appropriate colorectal cancer screening in the intervention group compared to the control group. Appropriate screening is a combined outcome measure using patient report of completion or non-completion of CRC screening tests and patient report of discussions about CRC screening with their provider at the index visit. The outcome will be measures six months after the index visit. The index visit is the patient/provider visit that occurred after the decision support intervention or control condition was administered.
Complete list of historical versions of study NCT01575990 on ClinicalTrials.gov Archive Site
  • Appropriate colorectal cancer screening decisions [ Time Frame: At baseline (after intervention or control was administered) ] [ Designated as safety issue: No ]
    The proportion of participants classified as having appropriate colorectal cancer screening decisions in the intervention group will be compared to the control group. Appropriate screening decision making is a combined outcome measure using patient report of intent to complete or not complete CRC screening tests and discussions about CRC screening with their provider. This outcome will be measured immediately after the patient and provider index visit. The index visit is the patient/provider visit that occurred after the decision support intervention or control condition was administered.
  • Appropriate screening and mediators [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    For the mediation analysis covariates will be evaluated as potential mediators. The potential mediators to be examined include adequate preparation for individualized decision making (adequate knowledge+ clear values); knowledge scores, screening preference before the index visit, decisional balance, reported discussion during the index visit, gender, previous screening, functional status, and literacy level.
  • Appropriate screening for health strata [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    Once we have tested our hypothesis for the main effects, we will also perform hypothesis-generating exploratory analyses to examine effect of the intervention in sub-groups of patients. We will examine the effect in the three strata (best, intermediate, worst health groups) defined by age and Charlson comorbidity score.
  • Appropriate screening for stool cards [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    For this analysis, appropriate screening test completion will include stool cards for all age groups and health groups. Analyses described for the primary outcome will be performed using this classification of appropriate screening test completion.
  • Appropriate colorectal cancer screening decisions [ Time Frame: Immediately after the patient/provider visit that occurred after the decision support intervention or control condition was administered ] [ Designated as safety issue: No ]
    The proportion of participants classified as having appropriate colorectal cancer screening decisions in the intervention group will be compared to the control group. Appropriate screening decision making is a combined outcome measure using patient report of intent to complete or not complete CRC screening tests and discussions about CRC screening with their provider. This outcome will be measured immediately after the patient and provider index visit. The index visit is the patient/provider visit that occurred after the decision support intervention or control condition was administered
  • Appropriate screening and mediators [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    For the mediation analysis covariates will be evaluated as potential mediators. The potential mediators to be examined include adequate preparation for individualized decision making (adequate knowledge+ clear values); knowledge scores, screening preference before the index visit, decisional balance, reported discussion during the index visit, gender, previous screening, functional status, and literacy level.
  • Appropriate screening for health strata [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    Once we have tested our hypothesis for the main effects, we will also perform hypothesis-generating exploratory analyses to examine effect of the intervention in sub-groups of patients. We will examine the effect in the three strata (best, intermediate, worst health groups) defined by age and Charlson comorbidity score.
  • Appropriate screening for stool cards [ Time Frame: Six months after intervention or control was adminstered ] [ Designated as safety issue: No ]
    For this analysis, appropriate screening test completion will include stool cards for all age group and health groups. Analyses described for the primary outcome will be performed using this classification of appropriate screening test completion.
Not Provided
Not Provided
 
Elders Preferences in Care Decisions
Improving Appropriate Colorectal Cancer Screening in Elderly Patients

The purpose of this research study is to explore ways to improve appropriate colorectal cancer (CRC) screening in the elderly by attempting to target screening in those most likely to benefit and avoiding screening in those least likely to benefit.

The investigators propose a randomized controlled trial at the patient level to determine the efficacy of a colorectal cancer screening decision support intervention for patients ages 70 to 84 within a clinical setting. The investigators hypothesize that the use of the intervention will prepare patients for individualized decision making with their providers and result in an improvement in appropriate CRC screening decisions and screening outcomes. To assess appropriate CRC screening decisions and screening, the investigators will use a classification scheme derived from the literature based on age and the Charlson Comorbidity Index. Using this scheme, appropriate screening will include screening for those in the best health because they are likely to benefit, no screening for those in the worst health because they are unlikely to benefit, and evidence of a discussion about CRC screening for those in the intermediate health group because the benefit is unclear.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
  • Early Detection of Cancer
  • Colon Cancer
  • Decision Making
  • Patient-Centered Care
  • Behavioral: Making A Decision About CRC Screening

    Targeted by age and gender with 3 components.

    1. Educational component
    2. Values clarification exercise
    3. Individualized decision making worksheet

    The intervention or control condition is administered before the index visit with the patient's provider.

    Other Names:
    • Making A Decision About Colon Cancer Screening Woman 70
    • Making A Decision About Colon Cancer Screening Woman 75
    • Making A Decision About Colon Cancer Screening Woman 80
    • Making A Decision About Colon Cancer Screening Men 70
    • Making A Decision About Colon Cancer Screening Men 75
    • Making A Decision About Colon Cancer Screening Men 80
  • Behavioral: Drivers 65 Plus
    This text booklet is provided as an attention control for those in the control arm and like the intervention is administered prior to the index visit with the patient's provider.
    Other Names:
    • Attention control
    • Control condition
  • Experimental: Making A Decision About CRC Screening
    A decision support intervention that is a literacy sensitive paper based tool with educational information targeted to the patient's age and gender.
    Intervention: Behavioral: Making A Decision About CRC Screening
  • Placebo Comparator: Drivers 65 Plus
    The placebo comparator is an attention control with information about driving tips for drivers age 65 and older.
    Intervention: Behavioral: Drivers 65 Plus
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
400
September 2014
March 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Men and women ages 70 to 84
  • Not up to date with colon cancer screening or surveillance

Exclusion Criteria:

  • Men and women younger than 70 years of age or older than 84
  • History of Colorectal Cancer
  • Inflammatory bowel disease
Both
70 Years to 84 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01575990
11-1638, PO1 HS 21133-01
No
Carmen Lewis, MD, MPH, University of North Carolina, Chapel Hill
University of North Carolina, Chapel Hill
  • Duke University
  • Agency for Healthcare Research and Quality (AHRQ)
Principal Investigator: Carmen L Lewis, MD, MPH University of North Carolina
Study Director: Rowena J Dolor, MD, MHS Duke University
University of North Carolina, Chapel Hill
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP